Moses O. Evbuomwan

1.5k total citations · 1 hit paper
13 papers, 818 citations indexed

About

Moses O. Evbuomwan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Moses O. Evbuomwan has authored 13 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Immunology. Recurrent topics in Moses O. Evbuomwan's work include CAR-T cell therapy research (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Brain Metastases and Treatment (2 papers). Moses O. Evbuomwan is often cited by papers focused on CAR-T cell therapy research (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Brain Metastases and Treatment (2 papers). Moses O. Evbuomwan collaborates with scholars based in United States, Nigeria and Malaysia. Moses O. Evbuomwan's co-authors include Stefania Pittaluga, Mark Raffeld, James N. Kochenderfer, Robert O. Carpenter, Frances T. Hakim, Shicheng Yang, Jeremy J. Rose, Ronald E. Gress, Elaine S. Jaffe and Brian A. Lewis and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Moses O. Evbuomwan

12 papers receiving 806 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma

2013 492 citations Robert O. Carpenter, Moses O. Evbuomwan et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Moses O. Evbuomwan

Since Specialization

Citations

This map shows the geographic impact of Moses O. Evbuomwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moses O. Evbuomwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moses O. Evbuomwan more than expected).

Fields of papers citing papers by Moses O. Evbuomwan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moses O. Evbuomwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moses O. Evbuomwan. The network helps show where Moses O. Evbuomwan may publish in the future.

Co-authorship network of co-authors of Moses O. Evbuomwan

This figure shows the co-authorship network connecting the top 25 collaborators of Moses O. Evbuomwan. A scholar is included among the top collaborators of Moses O. Evbuomwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moses O. Evbuomwan. Moses O. Evbuomwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Transformation of Lactotroph Pituitary Adenoma to Metastatic Pituitary Carcinoma: A Case Report 2025 ·Cureus ·(unknown), (unknown), (unknown), Suja S. Rajan, Moses O. Evbuomwan, Mark C. Smith	0
2	A Case Report of Sepsis-Induced Dilated Cardiomyopathy Secondary to Human Metapneumovirus Infection 2024 ·Cureus ·T Ingram, Moses O. Evbuomwan, (unknown)	2
3	Management of choroidal/ciliary body metastasis in the era of targeted cancer therapy 2024 ·Frontiers in Oncology ·Moses O. Evbuomwan, (unknown), (unknown), Farzad Jamshidi, Carryn M. Anderson, H. Culver Boldt, Elaine M. Binkley	1
4	Patient reported outcomes following whole brain radiotherapy in patients with brain metastases in NSIA-LUTH Cancer Center 2023 ·BMC Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), Victoria Ainsworth, Jennifer Chin, Moses O. Evbuomwan, Wilfred Ngwa	6
5	Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET 2017 ·Oncotarget ·Ido D. Weiss, Lyn M. Huff, Moses O. Evbuomwan, Xin Xu, (unknown), Daniel Velez, Satya P. Singh, Hongwei H. Zhang, Paul J. Gardina, (unknown), Liza Lindenberg, Timothy G. Myers, Chang H. Paik, David S. Schrump, Stefania Pittaluga, Peter L. Choyke, Tito Fojo, Joshua Μ. Farber	27
6	EGFR Mutations in Latinos From the United States and Latin America 2016 ·Journal of Global Oncology ·Ariel López-Chávez, Anish Thomas, Moses O. Evbuomwan, Liqiang Xi, Guinevere Chun, Tatiana Vidaurre, Óscar Arrieta, (unknown), Ana B. Oton, (unknown), Arun Rajan, Mark Raffeld, Seth M. Steinberg, (unknown), Giuseppe Giaccone	17
7	EGFR mutations in Latinos from the United States and Latin America. 2015 ·Journal of Clinical Oncology ·Ariel López-Chávez, Moses O. Evbuomwan, Liqiang Xi, Guinevere Chun, Tatiana Vidaurre, Óscar Arrieta, (unknown), Ana B. Oton, (unknown), Arun Rajan, (unknown), Mark Raffeld, Seth M. Steinberg, (unknown), Giuseppe Giaccone	4
8	Chemopreventive Activity of Plant Flavonoid Isorhamnetin in Colorectal Cancer Is Mediated by Oncogenic Src and β-Catenin 2013 ·Cancer Research ·Shakir M. Saud, Matthew R. Young, Yava Jones‐Hall, Lilia Ileva, Moses O. Evbuomwan, (unknown), Nancy H. Colburn, Young S. Kim, Gerd Bobe	81
9	B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma breakdown → 2013 ·Clinical Cancer Research ·Robert O. Carpenter, Moses O. Evbuomwan, Stefania Pittaluga, Jeremy J. Rose, Mark Raffeld, Shicheng Yang, Ronald E. Gress, Frances T. Hakim, James N. Kochenderfer	492
10	No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases 2013 ·Modern Pathology ·Jerzy Lasota, Liqiang Xi, (unknown), (unknown), Moses O. Evbuomwan, Zeng-Feng Wang, Mark Raffeld, Markku Miettinen	23
11	Loss-of-function of the protein kinase C δ (PKCδ) causes a B-cell lymphoproliferative syndrome in humans 2013 ·Blood ·Hye Sun Kuehn, Julie E. Niemela, Andréia Rangel-Santos, Mingchang Zhang, Stefania Pittaluga, Jennifer Stoddard, (unknown), Moses O. Evbuomwan, Debra A. Long Priel, Douglas B. Kuhns, (unknown), Thomas A. Fleisher, Gülbû Uzel, João Bosco Oliveira	99
12	Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival 2012 ·Blood ·Stella Maris Ranuncolo, Stefania Pittaluga, Moses O. Evbuomwan, Elaine S. Jaffe, Brian A. Lewis	65
13	B-Cell Maturation Antigen Is a Promising Target for Genetically-Modified T-Cell Therapy of Multiple Myeloma 2012 ·Blood ·Robert O. Carpenter, Moses O. Evbuomwan, Stefania Pittaluga, Jeremy J. Rose, Mark Raffeld, Shicheng Yang, Ronald E. Gress, Frances T. Hakim, James N. Kochenderfer	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact